SCHEMBL8499164

SCHEMBL8499164

COC(=O)CCc1ccc2ncc(-c3cccc(F)c3)cc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.52
PDGFRA P16234 1/20 0.52
MET P08581 1/20 0.48
CNR2 P34972 1/20 0.46
CDK8 P49336 4/20 0.44
PDE3B Q13370 2/20 0.43
PDE3A Q14432 2/20 0.43
P2RY12 Q9H244 2/20 0.43
VDR P11473 1/20 0.43
PPARD Q03181 1/20 0.43
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
PRNP P04156 1/20 0.41
GRIN2B Q13224 1/20 0.41
MAP4K4 O95819 1/20 0.41
CSNK1G2 P78368 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8499905 0.91 PDGFRB (0.52) PDGFRBPDGFRACNR2CDK8VDR
SCHEMBL8501202 0.86 FFAR1 (0.51) PDGFRBPDGFRAMETCDK8FFAR1
SCHEMBL8504167 0.85 CDK8 (0.47) PDGFRBPDGFRAMETCDK8GSK3A
SCHEMBL8501414 0.83 PDE3B (0.58) PDGFRBPDGFRAPDE3BPDE3AP2RY12
SCHEMBL8499494 0.80 THRB (0.51) CDK8LMNATP53
SCHEMBL28864796 0.79 MET (0.60) MET
SCHEMBL29870135 0.79 MET (0.60) MET
SCHEMBL8503378 0.78 PDGFRB (0.57) PDGFRBPDGFRACDK8LMNAMAP4K4
Hydrochloric Acid SCHEMBL8503257 0.78 MTNR1B (0.46) PDGFRBPDGFRACDK8GSK3AGSK3B
SCHEMBL8889522 0.76 PDGFRB (0.47) PDGFRBPDGFRAMETPPARDGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US claimed
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed